These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 29272354

  • 1. Impact of the Reclassification of "Noninvasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma" to "Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features" on the Bethesda System for Reporting Thyroid Cytopathology: A Large Academic Institution's Experience.
    Lau RP, Paulsen JD, Brandler TC, Liu CZ, Simsir A, Zhou F.
    Am J Clin Pathol; 2017 Dec 20; 149(1):50-54. PubMed ID: 29272354
    [Abstract] [Full Text] [Related]

  • 2. RISK OF MALIGNANCY IN THYROID CYTOLOGY: THE IMPACT OF THE RECLASSIFICATION OF NONINVASIVE FOLLICULAR THYROID NEOPLASM WITH PAPILLARY-LIKE NUCLEAR FEATURES (NIFTP).
    Ventura M, Melo M, Fernandes G, Carrilho F.
    Endocr Pract; 2019 Jul 20; 25(7):642-647. PubMed ID: 30865528
    [Abstract] [Full Text] [Related]

  • 3. Implementing noninvasive follicular thyroid neoplasm with papillary-like nuclear features may potentially impact the risk of malignancy for thyroid nodules categorized as AUS/FLUS and FN/SFN.
    Li W, Sciallis A, Lew M, Pang J, Jing X.
    Diagn Cytopathol; 2018 Feb 20; 46(2):148-153. PubMed ID: 29193839
    [Abstract] [Full Text] [Related]

  • 4. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology.
    Faquin WC, Wong LQ, Afrogheh AH, Ali SZ, Bishop JA, Bongiovanni M, Pusztaszeri MP, VandenBussche CJ, Gourmaud J, Vaickus LJ, Baloch ZW.
    Cancer Cytopathol; 2016 Mar 20; 124(3):181-7. PubMed ID: 26457584
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The importance of risk of neoplasm as an outcome in cytologic-histologic correlation studies on thyroid fine needle aspiration.
    Chen YH, Partyka KL, Dougherty R, Cramer HM, Wu HH.
    Diagn Cytopathol; 2020 Dec 20; 48(12):1237-1243. PubMed ID: 32716614
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. High risk of malignancy in cases with atypia of undetermined significance on fine needle aspiration of thyroid nodules even after exclusion of NIFTP.
    Özkara SK, Bayrak BY, Turan G.
    Diagn Cytopathol; 2020 Nov 20; 48(11):986-997. PubMed ID: 32745375
    [Abstract] [Full Text] [Related]

  • 19. Subclassification of Bethesda Atypical and Follicular Neoplasm Categories According to Nuclear and Architectural Atypia Improves Discrimination of Thyroid Malignancy Risk.
    Lim JXY, Nga ME, Chan DKH, Tan WB, Parameswaran R, Ngiam KY.
    Thyroid; 2018 Apr 20; 28(4):511-521. PubMed ID: 29596039
    [Abstract] [Full Text] [Related]

  • 20. Cytologic and clinical features of NIFTP: Can we diagnose based on preoperative fine-needle aspiration.
    Yan L, Sethi S, Park JW.
    Diagn Cytopathol; 2019 Dec 20; 47(12):1259-1266. PubMed ID: 31444953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.